Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leef BrandsLEEEF -2.89%30 Days Sales Outstanding is 30.40 as of Jun. 2026, which is 10% below its 10-year median of 33.78. GuruFocus rates LEEEF with a GF Score™ of 30/100 and a GF Value™ of $0.11 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 945 Drug Manufacturers companies, Leef Brands ranks better than 92.49% on this metric.
Leef Brands's average Accounts Receivable for the
three
months ended in Jun. 2026 was $2.42 Mil. Leef Brands's Revenue for the
three
months ended in Jun. 2026 was $7.28 Mil.
Hence, Leef Brands's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 30.40.
The historical rank and industry rank for Leef Brands's Days Sales Outstanding or its related term are showing as below:
LEEEF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.33 Med: 33.78 Max: 1981.92
Current: 24.56
During the past 13 years, Leef Brands's highest Days Sales Outstanding was 1981.92. The lowest was 21.33. And the median was 33.78.
LEEEF's Days Sales Outstanding is ranked better than 92.49% of 945
companies
in the Drug Manufacturers industry
Industry Median: 71.73
vs LEEEF: 24.56
Leef Brands's Days Sales Outstanding
increased
from Jun. 2025 (26.81) to Jun. 2026 (30.40).
Leef Brands (OTCPK:LEEEF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Leef Brands Days Sales Outstanding Related Terms
Leef Brands Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Leef Brands's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands Days Sales Outstanding vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Leef Brands's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a Days Sales Outstanding of 30.40 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Leef Brands and its competitors. This is 10% below median its historical median of 33.78. Over the past decade, Leef Brands' Days Sales Outstanding has ranged from 21.33 to 1,981.92. According to the industry distribution chart, Leef Brands ranks #71 out of 945 companies in the Drug Manufacturers industry, placing it in the top 7.5%.
Is Leef Brands' Days Sales Outstanding too high?
Leef Brands' current Days Sales Outstanding of 30.40 is 10% below median its 10-year median of 33.78. Over the past 10 years, this metric has ranged from a low of 21.33 to a high of 1,981.92. The Drug Manufacturers industry median Days Sales Outstanding is 71.73. Leef Brands' value of 30.40 is 57.6% below this industry median. Based on the distribution chart, Leef Brands ranks #71 out of 945 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Leef Brands has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' Days Sales Outstanding compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #71 out of 945 companies for Days Sales Outstanding. This places Leef Brands in the top 8% of its industry — outperforming the majority of peers. The industry median Days Sales Outstanding is 71.73. Leef Brands' value of 30.40 is 57.6% below this benchmark. Historically, Leef Brands' own Days Sales Outstanding has ranged from 21.33 to 1,981.92 over the past decade. While the company's 10-year median is 33.78 vs. the industry median of 71.73, Leef Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Drug Manufacturers company?
The median Days Sales Outstanding among Drug Manufacturers companies is 71.73, based on 945 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leef Brands's current Days Sales Outstanding of 30.40 is 57.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Leef Brands and its competitors. For the Drug Manufacturers industry, the median Days Sales Outstanding is 71.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current Days Sales Outstanding is 30.40, which is 10% below median its own 10-year median of 33.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.11, compared to a current price of $0.20 — trading 80.2% above its estimated fair value. The current Days Sales Outstanding is 30.40, which is 10% below median its 10-year median of 33.78 and 57.6% below the Drug Manufacturers industry median of 71.73. Leef Brands' overall GF Score™ is 30/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Leef Brands (LEEEF), the current Days Sales Outstanding is 30.40 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.20 is trading 80.2% above its estimated GF Value™ of $0.11.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
Days Sales Outstanding: 30.40 (10% below median its 10-year median of 33.78)
GF Value™: $0.11 vs. price of $0.20 (80.2% above fair value)
Industry Position: 57.6% below the Drug Manufacturers median (#71 of 945)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
30GF Score
Get the complete analysis for LEEEF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
